ArticleJournal of the Canadian Association of Gastroenterology2022

Efficacy of Intravenous Ustekinumab Reinduction in Patients With Crohn's Disease With a Loss of Response.

Valerie Heron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.